The clinical performance is complex and often involves multiple systemic burdens. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological evaluation.
The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many previously difficult-to-treat genetic metabolic diseases. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely scheduling according to disease changes.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of energy metabolism associated with carcinoma. The platform serves a team of domestic and foreign experts in the field of genetic metabolism linked to the Chinese international medical service system, providing the following services to patients: 1. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.